{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T02:29:41Z","timestamp":1785896981251,"version":"3.56.0"},"reference-count":71,"publisher":"American Veterinary Medical Association (AVMA)","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["javma"],"published-print":{"date-parts":[[2023,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n<jats:p>Regenerative medicine therapies have become significant tools for treatment of joint, soft tissue, and a variety of other conditions in animals and humans. Regenerative medicine aims to restore form and function of injured tissues using the body\u2019s own resources such as cells, fluids (ie, plasma and serum), and their resulting anti-inflammatory and prohealing cytokines. Platelet-rich plasma and other hemoderivatives have application for joint disorders such as osteoarthritis, cartilage injury, synovitis, and soft tissue injuries. These therapies achieve anti-inflammatory and healing effects without the use of corticosteroid therapy. This response is an advantage when treating young animals or human patients, and in animals with metabolic or hormonal issues such as equine pituitary pars intermedia dysfunction. Also, these therapies may have beneficial effects when traditional IA treatments such as corticosteroids and\/or hyaluronan are no longer effective at reducing joint inflammation and pain. Examples of hemoderivative regenerative therapies to be discussed include platelet-rich plasma, autologous conditioned serum, autologous protein solution, and \u03b1-2 macroglobulin.<\/jats:p>","DOI":"10.2460\/javma.22.12.0556","type":"journal-article","created":{"date-parts":[[2023,2,2]],"date-time":"2023-02-02T18:57:11Z","timestamp":1675364231000},"page":"301-308","source":"Crossref","is-referenced-by-count":10,"title":["A one-health perspective: use of hemoderivative regenerative therapies in canine and equine patients"],"prefix":"10.2460","volume":"261","author":[{"given":"Andris J.","family":"Kaneps","sequence":"first","affiliation":[{"name":"Kaneps Equine Sports Medicine and Surgery LLC, Beverly, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1272","reference":[{"issue":"3","key":"ref1","series-title":"Arthroscopy.","first-page":"429","article-title":"Platelet-rich plasma: a milieu of bioactive factors","volume":"28","author":"Boswell SG","year":"2012","unstructured":"Boswell SG, Cole BJ, Sundman EA, Karas V, Fortier LA. Platelet-rich plasma: a milieu of bioactive factors. Arthroscopy. 2012;28(3):429-439. doi:10.1016\/j.arthro.2011.10.01822284405"},{"key":"ref2","series-title":"Front Vet Sci.","first-page":"20","article-title":"A set of grand challenges for veterinary regenerative medicine","volume":"3","author":"Barrett JG","year":"2016","unstructured":"Barrett JG. A set of grand challenges for veterinary regenerative medicine. Front Vet Sci. 2016;3:20. doi:10.3389\/fvets.2016.0002026973846"},{"key":"ref3","series-title":"Front Vet Sci.","first-page":"73","article-title":"Canine platelet-rich plasma systems: a prospective analysis","volume":"2","author":"Carr BJ","year":"2016","unstructured":"Carr BJ, Canapp SO Jr, Mason DR, Cox C, Hess T. Canine platelet-rich plasma systems: a prospective analysis. Front Vet Sci. 2016;2:73. doi:10.3389\/fvets.2015.0007326779493"},{"issue":"2","key":"ref4","series-title":"J Orthop Res.","first-page":"211","article-title":"Effects of platelet-rich plasma on the quality of repair of mechanically induced core lesions in equine superficial digital flexor tendons: a placebo-controlled experimental study","volume":"28","author":"Bosch G","year":"2010","unstructured":"Bosch G, van Schie HT, de Groot MW,  Effects of platelet-rich plasma on the quality of repair of mechanically induced core lesions in equine superficial digital flexor tendons: a placebo-controlled experimental study. J Orthop Res. 2010;28(2):211-217. doi:10.1002\/jor.2098019714688"},{"issue":"4","key":"ref5","series-title":"Vet Surg.","first-page":"557","article-title":"Current use of biologic therapies for musculoskeletal disease: a survey of board-certified equine specialists","volume":"51","author":"Knott LE","year":"2022","unstructured":"Knott LE, Fonseca-Martinez BA, O\u2019Connor AM, Goodrich LR, McIlwraith CW, Colbath AC. Current use of biologic therapies for musculoskeletal disease: a survey of board-certified equine specialists. Vet Surg. 2022;51(4):557-567. doi:10.1111\/vsu.1380535383972"},{"issue":"3","key":"ref6","series-title":"PLoS One.","first-page":"e0194752","article-title":"Effect of leukocyte-reduced platelet-rich plasma on osteoarthritis caused by cranial cruciate ligament rupture: a canine gait analysis model","volume":"13","author":"Vilar JM","year":"2018","unstructured":"Vilar JM, Manera ME, Santana A,  Effect of leukocyte-reduced platelet-rich plasma on osteoarthritis caused by cranial cruciate ligament rupture: a canine gait analysis model. PLoS One. 2018;13(3):e0194752. doi:10.1371\/journal.pone.019475229554150"},{"issue":"5","key":"ref7","series-title":"BioDrugs.","first-page":"323","article-title":"Autologous conditioned serum in the treatment of orthopedic diseases: the orthokine therapy","volume":"21","author":"Wehling P","year":"2007","unstructured":"Wehling P, Moser C, Frisbie D,  Autologous conditioned serum in the treatment of orthopedic diseases: the orthokine therapy. BioDrugs. 2007;21(5):323-332. doi:10.2165\/00063030-200721050-00004 17896838"},{"issue":"1","key":"ref8","series-title":"Stem Cell Res Ther.","first-page":"126","article-title":"Effect of a single injection of autologous conditioned serum (ACS) on tendon healing in equine naturally occurring tendinopathies","volume":"6","author":"Geburek F","year":"2015","unstructured":"Geburek F, Lietzau M, Beineke A, Rohn K, Stadler PM. Effect of a single injection of autologous conditioned serum (ACS) on tendon healing in equine naturally occurring tendinopathies. Stem Cell Res Ther. 2015;6(1):126. doi:10.1186\/s13287-015-0115-026113022"},{"issue":"19","key":"ref9","series-title":"Animals (Basel).","first-page":"2717","article-title":"In vitro anti-inflammatory and regenerative effects of autologous conditioned serum from dogs with osteoarthritis","volume":"12","author":"Soontararak S","year":"2022","unstructured":"Soontararak S, Ardaum P, Senarat N,  In vitro anti-inflammatory and regenerative effects of autologous conditioned serum from dogs with osteoarthritis. Animals (Basel). 2022;12(19):2717. doi:10.3390\/ani1219271736230458"},{"issue":"12","key":"ref10","series-title":"J Am Acad Orthop Surg.","first-page":"739","article-title":"Platelet-rich plasma in orthopaedic applications: evidence-based recommendations for treatment","volume":"21","author":"Hsu WK","year":"2013","unstructured":"Hsu WK, Mishra A, Rodeo SR,  Platelet-rich plasma in orthopaedic applications: evidence-based recommendations for treatment. J Am Acad Orthop Surg. 2013;21(12):739-748. doi:10.5435\/JAAOS-21-12-739 24292930"},{"issue":"20","key":"ref11","series-title":"Int J Mol Sci.","first-page":"7794","article-title":"Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020","volume":"21","author":"Everts P","year":"2020","unstructured":"Everts P, Onishi K, Jayaram P, Lana JF, Mautner K. Platelet-rich plasma: new performance understandings and therapeutic considerations in 2020. Int J Mol Sci. 2020;21(20):7794. doi:10.3390\/ijms2120779433096812"},{"issue":"1","key":"ref12","series-title":"Expert Rev Hematol.","first-page":"97","article-title":"Evidence-based indications of platelet-rich plasma therapy","volume":"14","author":"Gupta S","year":"2021","unstructured":"Gupta S, Paliczak A, Delgado D. Evidence-based indications of platelet-rich plasma therapy. Expert Rev Hematol. 2021;14(1):97-108. doi:10.1080\/17474086.2021.186000233275468"},{"issue":"4","key":"ref13","series-title":"Arch Razi Inst.","first-page":"721","article-title":"Therapeutic potential of platelet-rich plasma in canine medicine","volume":"76","author":"Sharun K","year":"2021","unstructured":"Sharun K, Jambagi K, Dhama K, Kumar R, Pawde AM, Amarpal. Therapeutic potential of platelet-rich plasma in canine medicine. Arch Razi Inst. 2021;76(4):721-730. doi:10.22092\/ari.2021.355953.174935096308"},{"issue":"11","key":"ref14","series-title":"Wounds.","first-page":"329","article-title":"Platelet-rich plasma and other hemocomponents in veterinary regenerative medicine","volume":"30","author":"Tambella AM","year":"2018","unstructured":"Tambella AM, Martin S, Cantalamessa A, Serri E, Attili AR. Platelet-rich plasma and other hemocomponents in veterinary regenerative medicine. Wounds. 2018;30(11):329-336.30418162"},{"key":"ref15","series-title":"Front Vet Sci.","first-page":"641818","article-title":"A critical overview of the use of platelet-rich plasma in equine medicine over the last decade","volume":"8","author":"Camargo Garbin L","year":"2021","unstructured":"Camargo Garbin L, Lopez C, Carmona JU. A critical overview of the use of platelet-rich plasma in equine medicine over the last decade. Front Vet Sci. 2021;8:641818. doi:10.3389\/fvets.2021.64181833869321"},{"issue":"5","key":"ref16","series-title":"J Orthop Res.","first-page":"910","article-title":"Insulin-like growth factor-I improves cellular and molecular aspects of healing in a collagenase-induced model of flexor tendinitis","volume":"20","author":"Dahlgren LA","year":"2002","unstructured":"Dahlgren LA, van der Meulen MC, Bertram JE, Starrak GS, Nixon AJ. Insulin-like growth factor-I improves cellular and molecular aspects of healing in a collagenase-induced model of flexor tendinitis. J Orthop Res. 2002;20(5):910-919. doi:10.1016\/S0736-0266(02)00009-8"},{"issue":"11","key":"ref17","series-title":"Am J Sports Med.","first-page":"2259","article-title":"Platelet-rich plasma: from basic science to clinical applications","volume":"37","author":"Foster TE","year":"2009","unstructured":"Foster TE, Puskas BL, Mandelbaum BR, Gerhardt MB, Rodeo SA. Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009;37(11):2259-2272. doi:10.1177\/036354650934992119875361"},{"issue":"2","key":"ref18","series-title":"J Orthop Res.","first-page":"230","article-title":"Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons","volume":"25","author":"Schnabel LV","year":"2007","unstructured":"Schnabel LV, Mohammed HO, Miller BJ,  Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J Orthop Res. 2007;25(2):230-240. doi:10.1002\/jor.2027817106885"},{"issue":"8","key":"ref19","series-title":"J Orthop Res.","first-page":"1033","article-title":"Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression","volume":"27","author":"McCarrel T","year":"2009","unstructured":"McCarrel T, Fortier L. Temporal growth factor release from platelet-rich plasma, trehalose lyophilized platelets, and bone marrow aspirate and their effect on tendon and ligament gene expression. J Orthop Res. 2009;27(8):1033-1042. doi:10.1002\/jor.2085319170097"},{"issue":"4","key":"ref20","series-title":"Blood Rev.","first-page":"177","article-title":"Platelet alpha-granules: basic biology and clinical correlates","volume":"23","author":"Blair P","year":"2009","unstructured":"Blair P, Flaumenhaft R. Platelet alpha-granules: basic biology and clinical correlates. Blood Rev. 2009;23(4):177-189. doi:10.1016\/j.blre.2009.04.00119450911"},{"issue":"3","key":"ref21","series-title":"J Orthop Res.","first-page":"404","article-title":"Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus","volume":"26","author":"Moojen DJ","year":"2008","unstructured":"Moojen DJ, Everts PA, Schure RM,  Antimicrobial activity of platelet-leukocyte gel against Staphylococcus aureus. J Orthop Res. 2008;26(3):404-410. doi:10.1002\/jor.2051917960651"},{"key":"ref22","series-title":"Biomaterials.","first-page":"440","article-title":"Autologous fibrin scaffolds: when platelet- and plasma-derived biomolecules meet fibrin","volume":"192","author":"Anitua E","year":"2019","unstructured":"Anitua E, Nurden P, Prado R, Nurden AT, Padilla S. Autologous fibrin scaffolds: when platelet- and plasma-derived biomolecules meet fibrin. Biomaterials. 2019;192:440-460. doi:10.1016\/j.biomaterials.2018.11.02930500725"},{"issue":"2","key":"ref23","series-title":"Arch Orthop Trauma Surg.","first-page":"153","article-title":"Can platelet-rich plasma (PRP) improve bone healing? A comparison between the theory and experimental outcomes","volume":"133","author":"Malhotra A","year":"2013","unstructured":"Malhotra A, Pelletier MH, Yu Y, Walsh WR. Can platelet-rich plasma (PRP) improve bone healing? A comparison between the theory and experimental outcomes. Arch Orthop Trauma Surg. 2013;133(2):153-165. doi:10.1007\/s00402-012-1641-1 23197184"},{"key":"ref24","series-title":"Cochrane Database Syst Rev.","first-page":"CD006899","article-title":"Autologous platelet-rich plasma for treating chronic wounds","volume":"10","author":"Martinez-Zapata MJ","year":"2012","unstructured":"Martinez-Zapata MJ, Mart\u00ed-Carvajal AJ, Sol\u00e0 I,  Autologous platelet-rich plasma for treating chronic wounds. Cochrane Database Syst Rev. 2012;10:CD006899. doi:10.1002\/14651858.CD006899.pub223076929"},{"issue":"1","key":"ref25","series-title":"Sci Rep.","first-page":"12722","article-title":"Antimicrobial action of autologous platelet-rich plasma on MRSA-infected skin wounds in dogs","volume":"9","author":"Farghali HA","year":"2019","unstructured":"Farghali HA, AbdElKader NA, AbuBakr HO,  Antimicrobial action of autologous platelet-rich plasma on MRSA-infected skin wounds in dogs. Sci Rep. 2019;9(1):12722. doi:10.1038\/s41598-019-48657-531481694"},{"issue":"7","key":"ref26","series-title":"Curr Pharm Biotechnol.","first-page":"1131","article-title":"In search of a consensus terminology in the field of platelet concentrates for surgical use: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), fibrin gel polymerization and leukocytes","volume":"13","author":"Dohan Ehrenfest DM","year":"2012","unstructured":"Dohan Ehrenfest DM, Bielecki T, Mishra A,  In search of a consensus terminology in the field of platelet concentrates for surgical use: platelet-rich plasma (PRP), platelet-rich fibrin (PRF), fibrin gel polymerization and leukocytes. Curr Pharm Biotechnol. 2012;13(7):1131-1137. doi:10.2174\/13892011280062432821740379"},{"issue":"3-4","key":"ref27","series-title":"Vet Immunol Immunopathol.","first-page":"121","article-title":"Resolving an inflammatory concept: the importance of inflammation and resolution in tendinopathy","volume":"158","author":"Dakin SG","year":"2014","unstructured":"Dakin SG, Dudhia J, Smith RK. Resolving an inflammatory concept: the importance of inflammation and resolution in tendinopathy. Vet Immunol Immunopathol. 2014;158(3-4):121-127. doi:10.1016\/j.vetimm.2014.01.007"},{"issue":"6","key":"ref28","series-title":"Exp Ther Med.","first-page":"639","article-title":"Effects of leukocyte- and platelet-rich plasma on tendon disorders based on in vitro and in vivo studies (Review)","volume":"21","author":"Liu X","year":"2021","unstructured":"Liu X, Zhang R, Zhu B,  Effects of leukocyte- and platelet-rich plasma on tendon disorders based on in vitro and in vivo studies (Review). Exp Ther Med. 2021;21(6):639. doi:10.3892\/etm.2021.1007133968170"},{"issue":"19","key":"ref29","series-title":"J Bone Joint Surg Am.","first-page":"e143","article-title":"Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy","volume":"94","author":"McCarrel TM","year":"2012","unstructured":"McCarrel TM, Minas T, Fortier LA. Optimization of leukocyte concentration in platelet-rich plasma for the treatment of tendinopathy. J Bone Joint Surg Am. 2012;94(19):e143(1-8). doi:10.2106\/JBJS.L.00019"},{"issue":"1","key":"ref30","series-title":"Am J Sports Med.","first-page":"42","article-title":"Increasing platelet concentrations in leukocyte-reduced platelet-rich plasma decrease collagen gene synthesis in tendons","volume":"42","author":"Boswell SG","year":"2014","unstructured":"Boswell SG, Schnabel LV, Mohammed HO, Sundman EA, Minas T, Fortier LA. Increasing platelet concentrations in leukocyte-reduced platelet-rich plasma decrease collagen gene synthesis in tendons. Am J Sports Med. 2014;42(1):42-49. doi:10.1177\/036354651350756624136860"},{"issue":"3","key":"ref31","series-title":"Connect Tissue Res.","first-page":"203","article-title":"The influence of macrophage depletion on ligament healing","volume":"52","author":"Chamberlain CS","year":"2011","unstructured":"Chamberlain CS, Leiferman EM, Frisch KE,  The influence of macrophage depletion on ligament healing. Connect Tissue Res. 2011;52(3):203-211. doi:10.3109\/03008207.2010.51135521117894"},{"issue":"4","key":"ref32","series-title":"EFORT Open Rev.","first-page":"225","article-title":"Platelet-rich plasma: a narrative review","volume":"6","author":"Collins T","year":"2021","unstructured":"Collins T, Alexander D, Barkatali B. Platelet-rich plasma: a narrative review. EFORT Open Rev. 2021;6(4):225-235. doi:10.1302\/2058-5241.6.20001734040800"},{"key":"ref33","series-title":"BioMed Res Int.","first-page":"7538604","article-title":"Responders to platelet-rich plasma in osteoarthritis: a technical analysis","volume":"2017","author":"Milants C","year":"2017","unstructured":"Milants C, Bruy\u00e8re O, Kaux JF. Responders to platelet-rich plasma in osteoarthritis: a technical analysis. BioMed Res Int. 2017;2017:7538604. doi:10.1155\/2017\/753860428904970"},{"issue":"9","key":"ref34","series-title":"Regen Med.","first-page":"823","article-title":"Novel assessment of leukocyte-rich platelet-rich plasma on functional and patient-reported outcomes in knee osteoarthritis: a pilot study","volume":"16","author":"Jayaram P","year":"2021","unstructured":"Jayaram P, Kang GE, Heldt BL,  Novel assessment of leukocyte-rich platelet-rich plasma on functional and patient-reported outcomes in knee osteoarthritis: a pilot study. Regen Med. 2021;16(9):823-832. doi:10.2217\/rme-2021-003234424054"},{"issue":"9","key":"ref35","series-title":"Am J Vet Res.","first-page":"822","article-title":"Characteristics of canine platelet-rich plasma prepared with five commercially available systems","volume":"76","author":"Franklin SP","year":"2015","unstructured":"Franklin SP, Garner BC, Cook JL. Characteristics of canine platelet-rich plasma prepared with five commercially available systems. Am J Vet Res. 2015;76(9):822-827. doi:10.2460\/ajvr.76.9.82226309111"},{"issue":"3","key":"ref36","series-title":"Equine Vet J.","first-page":"319","article-title":"Equine autologous platelet concentrates: a comparative study between different available systems","volume":"47","author":"Hessel LN","year":"2015","unstructured":"Hessel LN, Bosch G, van Weeren PR, Ionita JC. Equine autologous platelet concentrates: a comparative study between different available systems. Equine Vet J. 2015;47(3):319-325. doi:10.1111\/evj.1228824773596"},{"issue":"2","key":"ref37","series-title":"Am J Sports Med.","first-page":"479","article-title":"Concentrations of blood components in commercial platelet-rich plasma separation systems: a review of the literature","volume":"47","author":"Oudelaar BW","year":"2019","unstructured":"Oudelaar BW, Peerbooms JC, Huis In \u2019t Veld R, Vochteloo AJH. Concentrations of blood components in commercial platelet-rich plasma separation systems: a review of the literature. Am J Sports Med. 2019;47(2):479-487. doi:10.1177\/036354651774611229337592"},{"issue":"6","key":"ref38","series-title":"Orthop J Sports Med.","first-page":"2325967115588896","article-title":"Autologous platelet-rich plasma preparations: influence of nonsteroidal anti-inflammatory drugs on platelet function","volume":"3","author":"Schippinger G","year":"2015","unstructured":"Schippinger G, Pr\u00fcller F, Divjak M,  Autologous platelet-rich plasma preparations: influence of nonsteroidal anti-inflammatory drugs on platelet function. Orthop J Sports Med. 2015;3(6):2325967115588896. doi:10.1177\/232596711558889626665098"},{"issue":"9","key":"ref39","series-title":"Biomedicines.","first-page":"2134","article-title":"Common medications which should be stopped prior to platelet-rich plasma injection","volume":"10","author":"Gupta A","year":"2022","unstructured":"Gupta A, Jeyaraman M, Maffulli N. Common medications which should be stopped prior to platelet-rich plasma injection. Biomedicines. 2022;10(9):2134. doi:10.3390\/biomedicines1009213436140235"},{"issue":"4","key":"ref40","series-title":"Ann Palliat Med.","first-page":"4823","article-title":"A narrative review of the research progress and clinical application of platelet-rich plasma","volume":"10","author":"Cao Y","year":"2021","unstructured":"Cao Y, Zhu X, Zhou R, He Y, Wu Z, Chen Y. A narrative review of the research progress and clinical application of platelet-rich plasma. Ann Palliat Med. 2021;10(4):4823-4829. doi:10.21037\/apm-20-222333691459"},{"issue":"1","key":"ref41","series-title":"J Am Acad Dermatol.","first-page":"e47","article-title":"Variables affecting the potential efficacy of platelet-rich plasma in dermatology","volume":"84","author":"Sharun K","year":"2021","unstructured":"Sharun K, Pawde AM. Variables affecting the potential efficacy of platelet-rich plasma in dermatology. J Am Acad Dermatol. 2021;84(1):e47-e48. doi:10.1016\/j.jaad.2020.08.08032858077"},{"issue":"12","key":"ref42","series-title":"Can Vet J.","first-page":"1266","article-title":"Simple tube centrifugation for processing platelet-rich plasma in the horse","volume":"53","author":"Fontenot RL","year":"2012","unstructured":"Fontenot RL, Sink CA, Werre SR, Weinstein NM, Dahlgren LA. Simple tube centrifugation for processing platelet-rich plasma in the horse. Can Vet J. 2012;53(12):1266-1272.23729823"},{"issue":"6","key":"ref43","series-title":"Animals (Basel).","first-page":"1478","article-title":"Three manual noncommercial methods to prepare equine platelet-rich plasma","volume":"11","author":"Segabinazzi LGTM","year":"2021","unstructured":"Segabinazzi LGTM, Podico G, Rosser MF, Nanjappa SG, Alvarenga MA, Canisso IF. Three manual noncommercial methods to prepare equine platelet-rich plasma. Animals (Basel). 2021;11(6):1478. doi:10.3390\/ani1106147834063777"},{"issue":"9","key":"ref44","series-title":"J Am Vet Med Assoc.","first-page":"1291","article-title":"A randomized controlled trial of the efficacy of autologous platelet therapy for the treatment of osteoarthritis in dogs","volume":"243","author":"Fahie MA","year":"2013","unstructured":"Fahie MA, Ortolano GA, Guercio V,  A randomized controlled trial of the efficacy of autologous platelet therapy for the treatment of osteoarthritis in dogs. J Am Vet Med Assoc. 2013;243(9):1291-1297. doi:10.2460\/javma.243.9.129124134578"},{"issue":"1","key":"ref45","series-title":"BMC Vet Res.","first-page":"207","article-title":"Platelet-rich plasma therapy in dogs with bilateral hip osteoarthritis","volume":"17","author":"Alves JC","year":"2021","unstructured":"Alves JC, Santos A, Jorge P. Platelet-rich plasma therapy in dogs with bilateral hip osteoarthritis. BMC Vet Res. 2021;17(1):207. doi:10.1186\/s12917-021-02913-x34090433"},{"key":"ref46","series-title":"Front Vet Sci.","first-page":"29","article-title":"Gait changes vary among horses with naturally occurring osteoarthritis following intra-articular administration of autologous platelet-rich plasma","volume":"3","author":"Mirza MH","year":"2016","unstructured":"Mirza MH, Bommala P, Richbourg HA, Rademacher N, Kearney MT, Lopez MJ. Gait changes vary among horses with naturally occurring osteoarthritis following intra-articular administration of autologous platelet-rich plasma. Front Vet Sci. 2016;3:29. doi:10.3389\/fvets.2016.0002927148544"},{"key":"ref47","series-title":"Front Vet Sci.","first-page":"205","article-title":"Extracorporeal shockwave therapy increases growth factor release from equine platelet-rich plasma in vitro","volume":"4","author":"Seabaugh KA","year":"2017","unstructured":"Seabaugh KA, Thoresen M, Gigu\u00e8re S. Extracorporeal shockwave therapy increases growth factor release from equine platelet-rich plasma in vitro. Front Vet Sci. 2017;4:205. doi:10.3389\/fvets.2017.0020529270410"},{"issue":"10","key":"ref48","series-title":"J Am Vet Med Assoc.","first-page":"1515","article-title":"Intralesional injection of platelet-rich plasma followed by controlled exercise for treatment of midbody suspensory ligament desmitis in Standardbred racehorses","volume":"232","author":"Waselau M","year":"2008","unstructured":"Waselau M, Sutter WW, Genovese RL, Bertone AL. Intralesional injection of platelet-rich plasma followed by controlled exercise for treatment of midbody suspensory ligament desmitis in Standardbred racehorses. J Am Vet Med Assoc. 2008;232(10):1515-1520. doi:10.2460\/javma.232.10.151518479242"},{"issue":"4","key":"ref49","series-title":"Scand J Med Sci Sports.","first-page":"554","article-title":"The effect of platelet-rich plasma on the neovascularization of surgically created equine superficial digital flexor tendon lesions","volume":"21","author":"Bosch G","year":"2011","unstructured":"Bosch G, Moleman M, Barneveld A, van Weeren PR, van Schie HT. The effect of platelet-rich plasma on the neovascularization of surgically created equine superficial digital flexor tendon lesions. Scand J Med Sci Sports. 2011;21(4):554-561. doi:10.1111\/j.1600-0838.2009.01070.x20459479"},{"key":"ref50","series-title":"Vet Med (Auckl).","first-page":"31","article-title":"Assessment of a single intra-articular stifle injection of pure platelet rich plasma on symmetry indices in dogs with unilateral or bilateral stifle osteoarthritis from long-term medically managed cranial cruciate ligament disease","volume":"11","author":"Venator KP","year":"2020","unstructured":"Venator KP, Frye CW, Gamble LJ, Wakshlag JJ. Assessment of a single intra-articular stifle injection of pure platelet rich plasma on symmetry indices in dogs with unilateral or bilateral stifle osteoarthritis from long-term medically managed cranial cruciate ligament disease. Vet Med (Auckl). 2020;11:31-38. doi:10.2147\/VMRR.S23859832215259"},{"issue":"2","key":"ref51","series-title":"Am J Vet Res.","first-page":"141","article-title":"Evaluation of a single intra-articular injection of autologous protein solution for treatment of osteoarthritis in horses","volume":"75","author":"Bertone AL","year":"2014","unstructured":"Bertone AL, Ishihara A, Zekas LJ,  Evaluation of a single intra-articular injection of autologous protein solution for treatment of osteoarthritis in horses. Am J Vet Res. 2014;75(2):141-151. doi:10.2460\/ajvr.75.2.14124471750"},{"key":"ref52","series-title":"Front Vet Sci.","first-page":"64","article-title":"The effect of autologous protein solution on the inflammatory cascade in stimulated equine chondrocytes","volume":"6","author":"Linardi RL","year":"2019","unstructured":"Linardi RL, Dodson ME, Moss KL, King WJ, Ortved KF. The effect of autologous protein solution on the inflammatory cascade in stimulated equine chondrocytes. Front Vet Sci. 2019;6:64. doi:10.3389\/fvets.2019.0006430895181"},{"issue":"6","key":"ref53","series-title":"Vet Surg.","first-page":"764","article-title":"Evaluation of a single intra-articular injection of autologous protein solution for treatment of osteoarthritis in a canine population","volume":"45","author":"Wanstrath AW","year":"2016","unstructured":"Wanstrath AW, Hettlich BF, Su L,  Evaluation of a single intra-articular injection of autologous protein solution for treatment of osteoarthritis in a canine population. Vet Surg. 2016;45(6):764-774. doi:10.1111\/vsu.12512"},{"issue":"1","key":"ref54","series-title":"J Knee Surg.","first-page":"63","article-title":"Autologous-conditioned serum: evidence for use in the knee","volume":"28","author":"Frisbie DD","year":"2015","unstructured":"Frisbie DD. Autologous-conditioned serum: evidence for use in the knee. J Knee Surg. 2015;28(1):63-66. doi:10.1055\/s-0034-154395625599270"},{"issue":"1","key":"ref55","series-title":"Br Med Bull.","first-page":"169","article-title":"Autologous conditioned serum for the treatment of osteoarthritis and other possible applications in musculoskeletal disorders","volume":"105","author":"Frizziero A","year":"2013","unstructured":"Frizziero A, Giannotti E, Oliva F, Masiero S, Maffulli N. Autologous conditioned serum for the treatment of osteoarthritis and other possible applications in musculoskeletal disorders. Br Med Bull. 2013;105(1):169-184. doi:10.1093\/bmb\/lds01622763153"},{"issue":"15","key":"ref56","series-title":"Int J Mol Sci.","first-page":"8005","article-title":"Anti-inflammatory therapeutic approaches to prevent or delay post-traumatic osteoarthritis (PTOA) of the knee joint with a focus on sustained delivery approaches","volume":"22","author":"Khella CM","year":"2021","unstructured":"Khella CM, Horvath JM, Asgarian R, Rolauffs B, Hart ML. Anti-inflammatory therapeutic approaches to prevent or delay post-traumatic osteoarthritis (PTOA) of the knee joint with a focus on sustained delivery approaches. Int J Mol Sci. 2021;22(15):8005. doi:10.3390\/ijms2215800534360771"},{"issue":"9","key":"ref57","series-title":"J Orthop Res.","first-page":"1320","article-title":"Autologous protein solution inhibits MMP-13 production by IL-1\u03b2 and TNF\u03b1-stimulated human articular chondrocytes","volume":"29","author":"Woodell-May J","year":"2011","unstructured":"Woodell-May J, Matuska A, Oyster M, Welch Z, O\u2019Shaughnessey K, Hoeppner J. Autologous protein solution inhibits MMP-13 production by IL-1\u03b2 and TNF\u03b1-stimulated human articular chondrocytes. J Orthop Res. 2011;29(9):1320-1326. doi:10.1002\/jor.2138421437966"},{"issue":"10","key":"ref58","series-title":"Inflamm Res.","first-page":"404","article-title":"The production of anti-inflammatory cytokines in whole blood by physico-chemical induction","volume":"52","author":"Meijer H","year":"2003","unstructured":"Meijer H, Reinecke J, Becker C, Tholen G, Wehling P. The production of anti-inflammatory cytokines in whole blood by physico-chemical induction. Inflamm Res. 2003;52(10):404-407. doi:10.1007\/s00011-003-1197-114520515"},{"issue":"8","key":"ref59","series-title":"Int J Sports Med.","first-page":"588","article-title":"Treatment of muscle injuries by local administration of autologous conditioned serum: a pilot study on sportsmen with muscle strains","volume":"25","author":"Wright-Carpenter T","year":"2004","unstructured":"Wright-Carpenter T, Klein P, Sch\u00e4ferhoff P, Appell HJ, Mir LM, Wehling P. Treatment of muscle injuries by local administration of autologous conditioned serum: a pilot study on sportsmen with muscle strains. Int J Sports Med. 2004;25(8):588-593. doi:10.1055\/s-2004-82130415532001"},{"issue":"5","key":"ref60","series-title":"Equine Vet J.","first-page":"516","article-title":"Autologous conditioned serum: the comparative cytokine profiles of two commercial methods (IRAP and IRAP II) using equine blood","volume":"43","author":"Hraha TH","year":"2011","unstructured":"Hraha TH, Doremus KM, McIlwraith CW, Frisbie DD. Autologous conditioned serum: the comparative cytokine profiles of two commercial methods (IRAP and IRAP II) using equine blood. Equine Vet J. 2011;43(5):516-521. doi:10.1111\/j.2042-3306.2010.00321.x21496084"},{"issue":"5","key":"ref61","series-title":"Vet Surg.","first-page":"582","article-title":"Cytokine and growth factor concentrations in canine autologous conditioned serum","volume":"45","author":"Sawyere DM","year":"2016","unstructured":"Sawyere DM, Lanz OI, Dahlgren LA, Barry SL, Nichols AC, Werre SR. Cytokine and growth factor concentrations in canine autologous conditioned serum. Vet Surg. 2016;45(5):582-586. doi:10.1111\/vsu.1250627357270"},{"issue":"3","key":"ref62","series-title":"Am J Vet Res.","first-page":"290","article-title":"Clinical, biochemical, and histologic effects of intra-articular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis","volume":"68","author":"Frisbie DD","year":"2007","unstructured":"Frisbie DD, Kawcak CE, Werpy NM, Park RD, McIlwraith CW. Clinical, biochemical, and histologic effects of intra-articular administration of autologous conditioned serum in horses with experimentally induced osteoarthritis. Am J Vet Res. 2007;68(3):290-296. doi:10.2460\/ajvr.68.3.29017331019"},{"issue":"2","key":"ref63","series-title":"Osteoarthritis Cartilage.","first-page":"152","article-title":"Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis","volume":"17","author":"Baltzer AW","year":"2009","unstructured":"Baltzer AW, Moser C, Jansen SA, Krauspe R. Autologous conditioned serum (Orthokine) is an effective treatment for knee osteoarthritis. Osteoarthritis Cartilage. 2009;17(2):152-160. doi:10.1016\/j.joca.2008.06.01418674932"},{"key":"ref64","series-title":"Front Vet Sci.","first-page":"602978","article-title":"A comparative review of autologous conditioned serum and autologous protein solution for treatment of osteoarthritis in horses","volume":"8","author":"Camargo Garbin L","year":"2021","unstructured":"Camargo Garbin L, Morris MJ. A comparative review of autologous conditioned serum and autologous protein solution for treatment of osteoarthritis in horses. Front Vet Sci. 2021;8:602978. doi:10.3389\/fvets.2021.60297833681323"},{"issue":"11","key":"ref65","series-title":"Am J Sports Med.","first-page":"2703","article-title":"Autologous protein solution injections for the treatment of knee osteoarthritis: 3-year results","volume":"48","author":"Kon E","year":"2020","unstructured":"Kon E, Engebretsen L, Verdonk P, Nehrer S, Filardo G. Autologous protein solution injections for the treatment of knee osteoarthritis: 3-year results. Am J Sports Med. 2020;48(11):2703-2710. doi:10.1177\/036354652094489132870042"},{"key":"ref66","series-title":"Front Vet Sci.","first-page":"697551","article-title":"Evaluation of autologous protein solution injection for treatment of superficial digital flexor tendonitis in an equine model","volume":"8","author":"Gaesser AM","year":"2021","unstructured":"Gaesser AM, Underwood C, Linardi RL,  Evaluation of autologous protein solution injection for treatment of superficial digital flexor tendonitis in an equine model. Front Vet Sci. 2021;8:697551. doi:10.3389\/fvets.2021.697551"},{"issue":"1","key":"ref67","series-title":"Curr Mol Biol Rep.","first-page":"1","article-title":"Alpha-2-macroglobulin, a native and powerful proteinase inhibitor, prevents cartilage degeneration disease by inhibiting majority of catabolic enzymes and cytokines","volume":"7","author":"Zhu M","year":"2021","unstructured":"Zhu M, Zhao B, Wei L, Wang S. Alpha-2-macroglobulin, a native and powerful proteinase inhibitor, prevents cartilage degeneration disease by inhibiting majority of catabolic enzymes and cytokines. Curr Mol Biol Rep. 2021;7(1):1-7. doi:10.1007\/s40610-020-00142-z"},{"issue":"4","key":"ref68","series-title":"Biochemistry.","first-page":"1176","article-title":"Protease activation of alpha2-macroglobulin modulates a chaperone-like action with broad specificity","volume":"47","author":"French K","year":"2008","unstructured":"French K, Yerbury JJ, Wilson MR. Protease activation of alpha2-macroglobulin modulates a chaperone-like action with broad specificity. Biochemistry. 2008;47(4):1176-1185. doi:10.1021\/bi701976f18171086"},{"issue":"7","key":"ref69","series-title":"Arthritis Rheumatol.","first-page":"1843","article-title":"Identification of \u03b12-macroglobulin as a master inhibitor of cartilage-degrading factors that attenuates the progression of posttraumatic osteoarthritis","volume":"66","author":"Wang S","year":"2014","unstructured":"Wang S, Wei X, Zhou J,  Identification of \u03b12-macroglobulin as a master inhibitor of cartilage-degrading factors that attenuates the progression of posttraumatic osteoarthritis. Arthritis Rheumatol. 2014;66(7):1843-1853. doi:10.1002\/art.3857624578232"},{"key":"ref70","series-title":"Front Pharmacol.","first-page":"849102","article-title":"\u03b12-macroglobulin-rich serum as a master inhibitor of inflammatory factors attenuates cartilage degeneration in a mini pig model of osteoarthritis induced by \u201cidealized\u201d anterior cruciate ligament reconstruction","volume":"13","author":"Zhao R","year":"2022","unstructured":"Zhao R, Wei X, Zhang C,  \u03b12-macroglobulin-rich serum as a master inhibitor of inflammatory factors attenuates cartilage degeneration in a mini pig model of osteoarthritis induced by \u201cidealized\u201d anterior cruciate ligament reconstruction. Front Pharmacol. 2022;13:849102. doi:10.3389\/fphar.2022.849102"},{"issue":"4","key":"ref71","series-title":"Int J Rheum Dis.","first-page":"654","article-title":"Early supplemental \u03b12-macroglobulin attenuates cartilage and bone damage by inhibiting inflammation in collagen II-induced arthritis model","volume":"22","author":"Li S","year":"2019","unstructured":"Li S, Xiang C, Wei X,  Early supplemental \u03b12-macroglobulin attenuates cartilage and bone damage by inhibiting inflammation in collagen II-induced arthritis model. Int J Rheum Dis. 2019;22(4):654-665. doi:10.1111\/1756-185X.1345730609267"}],"container-title":["Journal of the American Veterinary Medical Association"],"original-title":[],"link":[{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/261\/3\/javma.22.12.0556.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/javma\/261\/3\/javma.22.12.0556.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/avmajournals.avma.org\/downloadpdf\/journals\/javma\/261\/3\/javma.22.12.0556.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T12:59:30Z","timestamp":1741352370000},"score":1,"resource":{"primary":{"URL":"https:\/\/avmajournals.avma.org\/view\/journals\/javma\/261\/3\/javma.22.12.0556.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,1]]},"references-count":71,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.2460\/javma.22.12.0556","relation":{},"ISSN":["0003-1488"],"issn-type":[{"value":"0003-1488","type":"print"}],"subject":[],"published":{"date-parts":[[2023,3,1]]}}}